(Q39102331)

English

Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses

scientific article published on June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

multiple sclerosis

0 references

Ingrid van der Mei

object named as

Ingrid Van der Mei

2

0 references

object named as

Helen Tremlett

1

0 references

4

object named as

Leigh Blizzard

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Anne-Louise Ponsonby

8

object named as

Anne-Louise Ponsonby

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

6

object named as

Terence Dwyer

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

3

object named as

Fotini Pittas

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Glenys Paley

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Bruce Taylor

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Pharmacoepidemiology and Drug Safety

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

565-576

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1593

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1593

21 January 2018

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1593

21 January 2018

What's wrong with Bonferroni adjustments

1 reference

https://api.crossref.org/works/10.1002%2FPDS.1593

21 January 2018

Identifiers

10.1002/PDS.1593

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39102331&oldid=1859178375"